A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490): Difference between revisions

@@ Property / cites work @@
+Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
+Normal rank
@@ Property / cites work @@
+Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity
+Normal rank
@@ Property / cites work @@
+Q3998435
@@ Property / cites work: Q3998435 / rank @@
+Normal rank
@@ Property / cites work @@
+Dose-Finding Designs for HIV Studies
@@ Property / cites work: Dose-Finding Designs for HIV Studies / rank @@
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method for Ordered Groups
@@ Property / cites work: Continual Reassessment Method for Ordered Groups / rank @@
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Design and Analysis of Phase I Clinical Trials
@@ Property / cites work: Design and Analysis of Phase I Clinical Trials / rank @@
+Normal rank
@@ Property / cites work @@
+The Calculation of Posterior Distributions by Data Augmentation
+Normal rank
@@ Property / cites work @@
+Dose-Finding Based on Efficacy-Toxicity Trade-Offs
+Normal rank
@@ Property / cites work @@
+Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
+Normal rank
@@ Property / cites work @@
+A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
+Normal rank
@@ Property / cites work @@
+Robust EM Continual Reassessment Method in Oncology Dose Finding
+Normal rank